Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia patients have higher heart disease risk; statins and finasteride may help.

The Rotterdam Study investigates diseases in older adults and has produced many research findings.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Non-obese women with hair loss have higher heart disease risk.

The Rotterdam Study aims to understand various diseases in older adults.

Adapted classification better assesses male pattern hair loss and its link to heart disease.

Long-term high testosterone levels can improve bone density and reduce body fat but may increase the risk of prostate cancer and high blood pressure.

Increased free testosterone can lead to stronger bones and less body fat but also higher risks of prostate cancer, hair loss, spine issues, and high blood pressure.

Metabolic syndrome's individual issues are real and need treatment to reduce diabetes and heart disease risks.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

Astaxanthin is a safe antioxidant that may improve heart, skin, eye health, and physical performance, and help manage chronic diseases.

Lignans and neolignans from plants may help protect against various health issues, including cancer and heart disease.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Prediabetes may be a risk factor for hair loss.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Balding men, especially young ones, may have higher risk of heart issues and diabetes; check cholesterol levels.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

The document concludes that more research is needed to fully understand the causes of PCOS.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

People with hair loss have worse cholesterol levels, possibly linking hair loss to heart problems.

Most people in Turkey start getting gray hair around 33 years old, with factors like age, education, hair loss, skin type, family history, and anxiety playing a role.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

Men with severe hair loss are more likely to have metabolic syndrome, a condition linked to heart disease.

Women with PCOS often have metabolic issues like insulin resistance and a higher risk of diabetes and abnormal lipid levels.

Small hormonal imbalances can cause significant health problems, so more sensitive testing for hormone-disrupting chemicals is needed.

Certain genetic mutations can lower bad cholesterol and reduce heart disease risk, leading to effective cholesterol-lowering drugs.

Women with PCOS have higher risks of heart disease, type 2 diabetes, and endometrial cancer.